Investor Update
Basel 24 September 2009
Anti-Cancer Agent Xeloda and Avastin Obtained Approval for Additional Indication of Colorectal Cancer
Dear Investor,
Please find enclosed a press release by Chugai:
Basel 24 September 2009
Dear Investor,
Please find enclosed a press release by Chugai: